Zdrowie i gospodarka · 08/05/2001

FDA Releases Draft Guidance on Statistical Aspects of Rodent Carcinogenicity Studies for Pharmaceuticals

The FDA has made available a draft guidance document aimed at helping pharmaceutical sponsors design and analyze animal studies to assess potential carcinogenic effects, and submit the results to the FDA for review.